Nachrichten zur Amgen Inc. Aktie

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

Amgen (AMGN) Outperforms Broader Market: What You Need to Know

The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.…

Why Amgen Stock Popped by 4% Today

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the…

2 Dividend Stocks to Buy on the Dip and Hold Forever

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic…

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.…

Amgen (AMGN) Stock Moves 1.03%: What You Should Know

In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.…

Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript

…

Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Amgen (AMGN) closed at $272.44, marking a -5.84% move from the previous day.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Members of Congress Are Pouring Millions Into These 7 Surprising Stocks

In this video, I will review some of the stock purchases made by members of the U.S. Congress. Politicians such…

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical…

Amgen: Imdelltra Data And Q1 Results Impress

…

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Amgen (AMGN) closed at $297.29 in the latest trading session, marking a +1.88% move from the prior day.…

Amgen Inc. (AMGN) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Amgens Strategic Path - Navigating Patent Expiries With Promising New Therapies

…

Amgens Imdelltra Cuts Lung Cancer Death Risk by 40% in Phase III

AMGNs Imdelltra slashes lung cancer death risk by 40% in Phase III, extending survival by over five months compared to…

3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock…

"If Walmart Is Under Pressure to Raise Prices, Its Going to Have Broader Effects on the Economy."

In this podcast, Motley Fool analyst Tim Beyers and host Ricky Mulvey discuss: Walmarts response to tariff uncertainty. Netflixs booming ad business. How…

The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now

The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500…

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…

Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript)

…

Amgen Aktie: Chancen in der Pipeline trotz Prolia-Verlust

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Guggenheim Securities: Vamil Divan, Analyst von Guggenheim Securities, nimmt die Bewertung der Aktie von Amgen…

Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?

At current levels, we believe AMGN scores above BMY, buoyed by solid fundamentals and recent positive estimate revisions.…

Dividendenbekanntmachungen (16.05.2025)

Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMGEN INC US0311621009 2,38 USD 2,1268 EUR ARTESIAN RESOURCES CORPORATION US0431132085 0,3074 USD 0,2746…

1 No-Brainer Dividend Index Fund to Buy Right Now for Less Than $500 -- and Another Dividend Fund Yielding 11%

Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing,…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…

Amgen outlook revised to stable at S&P, debt reduction continues By Investing.com

Amgen outlook revised to stable at S&P, debt reduction continues…

2 Unstoppable Dividend Stocks to Buy and Hold Forever

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the…

Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1

…

Amgen verdient dank starker Nachfrage überraschend viel

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank einer starken Nachfrage im abgelaufenen Quartal…

Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut verlaufenen Quartal optimistisch…

AKTIE IM FOKUS: Amgen sacken nach Studiendaten zum Abnehmmittel Maritide ab

NEW YORK (dpa-AFX) - Die Aktien von Amgen sind am Dienstag nach Studiendaten zum Abnehmmittel…

Amgen legt deutlich zu - keine Neuigkeiten zu Abnehmmittel Maritide

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen ist im dritten Quartal dank einer hohen Nachfrage…

Amgen schweigt zu Maritide - Gemischte Zahlen und Ausblick drücken Kurs

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat mit gemischt ausgefallenen Quartalszahlen und einem wenig…

Amgen steigert Umsatz kräftig - Abnehmpille sorgt beim Aktienkurs für Höhenflüge

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seinen Umsatz dank erheblich mehr verkaufter Medikamente…

Amgen steigert Quartalsumsatz kräftig - Fortsetzung im laufenden Jahr erwartet

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hofft nach der Übernahme von Horizon Therapeutics auf…

Amgen kappt Gewinnprognose wegen Abschreibung - Umsatzziel erneut erhöht

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seine Gewinnprognose wegen einer Abschreibung auf eine…

Amgen wird noch optimistischer

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seine Erwartungen an das laufende Geschäftsjahr erneut…

Amgen wird etwas optimistischer

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seine Erwartungen an das laufende Geschäftsjahr etwas…

Amgen mit Gewinnrückgang im Schlussquartal

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat im vierten Quartal einen leichten Dämpfer erhalten.…

WDH: Amgen schließt Quartal überraschend gut ab - Aktienkurs steigt

(technische Wiederholung) THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank starker…

Amgen schließt Quartal überraschend gut ab - Aktienkurs steigt

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank starker Medikamentenverkäufe und einer erfolgreichen Kostenkontrolle…

Amgen überrascht mit starken Produktverkäufen

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank starker Medikamentenverkäufe im zweiten Quartal mehr…